A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis

Abstract Background Ramucirumab is a monoclonal antibody targeting vascular endothelial growth factor receptor 2 (VEGFR-2). Ramucirumab either alone or in combination with paclitaxel (PTX) has been found to be safe and effective for patients with previously treated advanced gastric cancer. One of th...

Full description

Bibliographic Details
Main Authors: Shinya Urakawa, Daisuke Sakai, Yasuhiro Miyazaki, Toshihiro Kudo, Aya Katou, Chiaki Inagaki, Koji Tanaka, Tomoki Makino, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Shuji Takiguchi, Taroh Satoh, Masaki Mori, Yuichiro Doki
Format: Article
Language:English
Published: SpringerOpen 2017-12-01
Series:Surgical Case Reports
Subjects:
Ramucirumab
Gastrointestinal perforation
Gastric cancer
Small bowel metastasis
Online Access:http://link.springer.com/article/10.1186/s40792-017-0399-7

Internet

http://link.springer.com/article/10.1186/s40792-017-0399-7

Similar Items